83345-63-5 Usage
Uses
Used in Pharmaceutical Industry:
8-Carboxyoctyl-D-Galactopyranoside is used as a component for the preparation of sugar-modified polylysine derivatives, which serve as organ-targeting pharmaceutical carriers. This application is significant as it allows for the development of targeted drug delivery systems, potentially improving the efficacy and reducing side effects of certain medications.
Used in Chemical Synthesis:
8-Carboxyoctyl-D-Galactopyranoside also serves as an impurity in the production of 9-(β-D-Galactopyranosyloxy)nonanoic Acid. Its presence in this process highlights its role in the synthesis of other valuable chemical compounds, contributing to the development of new materials and products.
Check Digit Verification of cas no
The CAS Registry Mumber 83345-63-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,3,4 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 83345-63:
(7*8)+(6*3)+(5*3)+(4*4)+(3*5)+(2*6)+(1*3)=135
135 % 10 = 5
So 83345-63-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H28O8/c16-9-10-12(19)13(20)14(21)15(23-10)22-8-6-4-2-1-3-5-7-11(17)18/h10,12-16,19-21H,1-9H2,(H,17,18)/t10?,12-,13-,14?,15+/m0/s1
83345-63-5Relevant academic research and scientific papers
A simple synthesis of 8-(methoxycarbonyl)octyl 3,6-di-O-(α-D-mannopyranosyl)-α-D-mannopyranoside and derivatives and their use in the preparation of neoglycoconjugates
Becker, Bernd,Furneaux, Richard H.,Reck, Folkert,Zubkov, Oleg A.
, p. 148 - 158 (2007/10/03)
8-(Methoxycarbonyl)octyl 3,6-di-O-(α-D-mannopyranosyl)-α-D-mannopyranoside (10) was synthesized in 54% yield by regioselective diglycosylation of unprotected mannoside 4, employing the trichloroacetimidate donor 1, followed by debenzoylation. Derivatives
Synthesis and antidiuretic activities of novel glycoconjugates of arginine-vasopressin
Susaki, Hiroshi,Suzuki, Kokichi,Ikeda, Masahiro,Yamada, Harutami,Watanabe, Hiroshi K.
, p. 1530 - 1537 (2007/10/03)
Arginine-vasopressin (AVP) was acylated with various acyl azides (2a-j) in pH 9.1 buffer to give AVP derivatives (11a-j) modified at the tyrosine side chain with a carbohydrate via a spacer arm. Glycoconjugates of AVP modified at the N-terminal amide (12a
